On a relative basis, the stock has outperformed the S&P 500 by 0.52% in the past 4 weeks, but has underperformed the S&P 500 in the past 1 week. The stock has continued its bullish performance both in the near-term and the medium-term, as the stock is up 0.08% in the last 1 week, and is up 3.02% in the past 4 weeks. Buying continues as the stock moves higher, suggesting a strong appetite for the stock.
Baxter International (NYSE:BAX): The stock opened at $48.30 on Friday but the bulls could not build on the opening and the stock topped out at $48.40 for the day. The stock traded down to $48.02 during the day, due to lack of any buying support eventually closed down at $48.06 with a loss of -0.04% for the day. The stock had closed at $48.08 on the previous day. The total traded volume was 2,323,794 shares.
The stock has recorded a 20-day Moving Average of 1.8% and the 50-Day Moving Average is 5.65%. Baxter International Inc. is up 6.96% in the last 3-month period. Year-to-Date the stock performance stands at 26.72%.
Baxter International (BAX) : 8 Wall Street analysts covering Baxter International (BAX) believe that the average level the stock could reach for the short term is $50. The maximum price target given is $60 and the minimum target for short term is around $46, hence the standard deviation is calculated at $4.5.
Baxter International Inc. (Baxter) is a diversified healthcare company. The Company operates in two segments: BioScience segment, which include three commercial franchises: Hemophilia, BioTherapeutics and BioSurgery, and Medical Products segment, which include four commercial franchises: Fluid Systems, Renal, Specialty Pharmaceuticals and BioPharma Solutions. Its BioScience processes recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha-1 antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions, and biosurgery products. Its Medical Products manufactures intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, infusion pumps and inhalation anesthetics. Its products are used in hospitals, kidney dialysis centers and nursing homes, among others.